The urgent need to recognize and properly address prenatal-onset group B Streptococcus disease
Natália Silva Costa, Laura Maria Andrade Oliveira, Tomislav Meštrović and 3 more
International Journal of Infectious Diseases · 2022
doi:10.1016/j.ijid.2022.10.016 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
October is the “Prenatal-onset GBS Disease Recognition Month”, which brings into focus the importance of preventing neonatal infections. Neonatal infections are a remarkable cause of infant morbidity and mortality worldwide and have become the dominant component of all child mortality as overall infant mortality rates decline. Among bacteria associated with neonatal infections, Streptococcus agalactiae or group B Streptococcus (GBS) stands out as a leading agent of neonatal meningitis, pneumonia, and sepsis since the 1960s.
Abstract licence: CC BY-NC-ND
References4
- 2.
3 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.